GAP43 and Alzheimer disease: Furthermore, higher CSF levels of GAP-43 have been associated with worse cognitive performance and faster symptom worsening in AD, indicating that GAP-43 may be a proxy of synaptic dysfunction that parallels cognitive decline in the disease16,18.